Holen Sie sich die Stockscreener-App
25.22
3.53%
0.86
Vorhandelsmarkt:
24.45
-0.77
-3.05%
Schlusskurs vom Vortag:
$24.36
Offen:
$27.115
24-Stunden-Volumen:
7.27M
Relative Volume:
2.64
Marktkapitalisierung:
$2.17B
Einnahmen:
$19.32M
Nettoeinkommen (Verlust:
$-141.47M
KGV:
-14.97
EPS:
-1.6851
Netto-Cashflow:
$-120.48M
1W Leistung:
+10.81%
1M Leistung:
+12.44%
6M Leistung:
+59.32%
1J Leistung:
+129.69%
1-Tages-Spanne:
$22.21
$27.23
1-Wochen-Bereich:
$22.05
$27.23
52-Wochen-Spanne:
$9.71
$29.94
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Branche
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Vergleichen Sie LQDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
25.22 | 2.10B | 19.32M | -141.47M | -120.48M | -1.6851 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-15 | Fortgesetzt | Jefferies | Buy |
| 2025-05-19 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Eingeleitet | Raymond James | Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
Expert Outlook: Liquidia Through The Eyes Of 7 Analysts - Benzinga
BTIG Reiterates Buy Rating for LQDA with $49 Price Target | LQDA Stock News - GuruFocus
Liquidia stock price target raised to $47 from $41 at Raymond James - Investing.com
Will Liquidia Corporation stock reach Wall Street targetsInsider Buying & AI Based Buy/Sell Signal Reports - newser.com
Beyond the Balance Sheet: What SWOT Reveals About Liquidia Corp (LQDA) - GuruFocus
Liquidia Corp (LQDA) Q3 2025 Earnings Call Highlights: Strong YUTREPIA Sales Drive Positive ... - Yahoo! Finance UK
Transcript : Liquidia Corporation, Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
Liquidia Q3 2025 slides: YUTREPIA drives profitability as adoption accelerates - Investing.com
Earnings call transcript: Liquidia Technologies’ Q3 2025 beats expectations - Investing.com
Liquidia Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Liquidia : 3Q25 Earnings Call Presentation 110225 745pm posted - MarketScreener
Will Liquidia Corporation stock benefit from automationJuly 2025 Macro Moves & Verified Entry Point Signals - newser.com
Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences - The Manila Times
Liquidia (NASDAQ: LQDA) to present at UBS, Jefferies conferences; webcasts available online - Stock Titan
Liquidia (LQDA) Reports Strong Q3 Earnings, Beats Expectations - GuruFocus
Liquidia Q3 Net Loss Narrows, Revenue Rises; Shares Up Pre-Bell - MarketScreener
Liquidia’s YUTREPIA Drives Unexpected Operating Profits In Q3 - Finimize
Liquidia Corp SEC 10-Q Report - TradingView
Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update - TradingView
Pulmonary drug developer Liquidia posts operating profit in first full quarter of YUTREPIA sales - MarketScreener
Liquidia Corporation Reports $51.7 Million in Q3 2025 Net Sales of YUTREPIA™ and Achieves Profitability - Quiver Quantitative
Earnings Flash (LQDA) Liquidia Corporation Reports Q3 Revenue $54.3M, vs. FactSet Est of $18.8M - MarketScreener
Will Liquidia Corporation (LT4) stock outperform small cap peersBull Run & Risk Controlled Swing Trade Alerts - newser.com
Liquidia Corp (LQDA) Q3 2025 Earnings Report Preview: What To Ex - GuruFocus
How Liquidia Corporation stock performs in stagflationQuarterly Portfolio Review & Weekly Hot Stock Watchlists - newser.com
Is Liquidia Corporation showing signs of accumulationEarnings Overview Report & Fast Momentum Stock Entry Tips - newser.com
Does Liquidia Corporation show high probability of reboundTrade Analysis Report & Daily Volume Surge Signals - newser.com
Will Liquidia Corporation (LT4) stock profit from automation waveTrade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Liquidia (NASDAQ:LQDA) CAO Dana Boyle Sells 1,073 Shares - MarketBeat
Insider Selling: Liquidia (NASDAQ:LQDA) Insider Sells 692 Shares of Stock - MarketBeat
Liquidia CorpUnit enters exclusive licensing agreement with VecturaSEC filing - MarketScreener
Has Liquidia Corporation formed a bullish divergence2025 Market Sentiment & Real-Time Stock Price Movement Reports - newser.com
Will Liquidia Corporation (LT4) stock sustain uptrend momentumInsider Buying & Safe Capital Allocation Plans - newser.com
What dividend safety rating applies to Liquidia Corporation (LT4) stockShort Setup & Low Drawdown Momentum Ideas - newser.com
Liquidia (LQDA) Expected to Announce Earnings on Monday - MarketBeat
What sentiment indicators say about Liquidia Corporation stockEarnings Overview Summary & Stock Portfolio Risk Management - newser.com
Will Liquidia Corporation stock keep outperforming rivals2025 Price Targets & Safe Entry Zone Tips - newser.com
Will Liquidia Corporation stock attract more institutional investorsBuy Signal & Accurate Entry/Exit Alerts - newser.com
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025 - Quiver Quantitative
Liquidia (NASDAQ: LQDA) sets Nov. webcast at 8:30 a.m. ET to discuss Q3 results - Stock Titan
Liquidia's (LQDA) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Liquidia Corp-Aktie (LQDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Boyle Dana | Chief Accounting Officer |
Oct 27 '25 |
Sale |
22.93 |
1,073 |
24,604 |
184,338 |
| Schundler Russell | General Counsel |
Oct 13 '25 |
Sale |
23.41 |
7,839 |
183,511 |
576,017 |
| Kaseta Michael | CFO and COO |
Oct 13 '25 |
Sale |
23.41 |
11,630 |
272,258 |
352,646 |
| Moomaw Scott | Chief Commercial Officer |
Oct 13 '25 |
Sale |
23.41 |
4,900 |
114,709 |
153,462 |
| Saggar Rajeev | Chief Medical Officer |
Oct 13 '25 |
Sale |
23.41 |
5,327 |
124,705 |
247,930 |
| Boyle Dana | Chief Accounting Officer |
Oct 13 '25 |
Sale |
23.41 |
1,238 |
28,982 |
185,411 |
| JEFFS ROGER | Chief Executive Officer |
Oct 13 '25 |
Sale |
23.41 |
20,261 |
474,310 |
1,032,973 |
| Adair Jason | Chief Business Officer |
Oct 13 '25 |
Sale |
23.41 |
3,670 |
85,915 |
175,690 |
| Krepp Sarah | Chief Human Resource Officer |
Oct 13 '25 |
Sale |
23.41 |
1,691 |
39,586 |
141,439 |
| SINGH RAMAN | Director |
Sep 15 '25 |
Option Exercise |
2.55 |
45,524 |
115,865 |
76,779 |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):